What is the impact of COVID-19 on Multiple Sclerosis patients?
The Hospital Clínic de Barcelona’s Multiple Sclerosis and Neuroimmunology Department has conducted a study to ascertain the impact of COVID-19 on Mul1
The Hospital Clínic de Barcelona’s Multiple Sclerosis and Neuroimmunology Department has conducted a study to ascertain the impact of COVID-19 on Mul1
A study published in GUT, jointly led by Ki Up Lee of the University of Ulsan, South Korea, and José C. Fernández-Checa, leader of the IDIBAPS-IIBB-C1
A study published in the Journal of Hepatology shows for the first time the efficacy of the drug lanifibranor in portal hypertension and hepatic fibr1
The network was presented on Thursday, 18 February 2021. The network is promoted by the Institute of Photonic Sciences (ICFO) and groups several hosp1
This February, the projects awarded in the latest call for applications of the Horizon 2020 FET Open program on research and innovation actions (FET1
Researchers from IDIBAPS-Hospital Clínic and CNAG-CRG in Barcelona have led a study to draw the first 3D maps of the genome of healthy and cancerous1
The journal Plos One has published a study that describes a new computational method that makes it possible to better identify the relationship betwe1
Beà, a researcher of the IDIBAPS group Molecular pathology in lymphoid neoplasms, has authored 119 articles, 30 of them as the principal author, with1
Dr. Sabela Lens, who was a winner of the 2020 Rising Star Award of the Spanish Society of Digestive Disease (SEPD), was given the United European Gas1
A study coordinated by Clínic-IDIBAPS researchers, published in the journal Scientific Reports, shows that people aged between 18 and 70 years who we1